OC 8491 PrEPVacc: a phase III, MAMS adaptive prophylactic HIV vaccine trial with a second randomisation to compare F/TAF with TDF/FTC PrEP

Joseph, Sarah; Kaleebu, Pontiano; Ruzagira, Eugene; Hansen, Christian Holm; Seeley, Janet; Basajja, Vincent; Weber, Jonathan; Fox, Julie; Kingsley, Cherry; Aboud, Said; +15 more... Lyamuya, Eligius; Maganga, Lucas; Pamba, Doreen; Ramjee, Gita; Yssel, Justin; Viegas, Edna; Jani, Ilesh; Priddy, Fran; Nilsson, Charlotta; Kroidl, Arne; Pantaleo, Giuseppe; Robb, Merlin; Crook, Angela; Dunne, David; Mccormack, Sheena; (2019) OC 8491 PrEPVacc: a phase III, MAMS adaptive prophylactic HIV vaccine trial with a second randomisation to compare F/TAF with TDF/FTC PrEP. In: The Ninth Forum of the European & Developing Countries Clinical Trials Partnership, 17-21 Sep 2018. DOI: https://doi.org/10.1136/bmjgh-2019-edc.23

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/bmjgh-2019-edc.23

Abstract

Item Type Conference or Workshop Item
Faculty and Department Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
Elements ID 176007

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar